The Middle East & Africa vital signs monitoring devices market was valued at US$ 689.93 million in 2022 and is expected to reach US$1.65 billion by 2030; it is estimated to grow at a CAGR of 11.5% from 2022 to 2030.
The growth of the country's medical devices and pharmaceutical sector is majorly attributed to the vast population and increasing prevalence of chronic diseases. The health systems in Saudi Arabia are witnessing increasing adoption of advanced medical devices to keep track of patient's health conditions. Greater awareness of health issues and an increase in the consumption of healthcare services sustain a substantial market for medical equipment. Also, the government and other organizations conduct conferences and symposiums and publish many research studies about monitoring devices. For instance, the Hospital and Research Center in Riyadh, Saudi Arabia, published a study about "perspectives from COPD subjects on portable long-term oxygen therapy devices" in June 2019. All these factors are likely to drive the market during the forecast period.
Also, Healthcare companies in the UAE strive to adopt cutting-edge healthcare technologies that provide their patients with unparalleled quality of service and the best treatment plans. In addition, the growing healthcare expenditure increases the demand for medical devices and pharmaceuticals. According to a "UAE Health Spending" study published in Healthcare Radius, the UAE spends ~3.5% of its GDP on healthcare, with approximately 70% coming from public spending and only 30% from the private sector. The UAE government has allocated US$ 1.33 billion (8.4% of the total budget) for healthcare and community protection in the federal budget for 2022-2026.
Based on product, the Middle East & Africa vital signs monitoring devices market is segmented into pulse oximeters, blood pressure monitors, temperature monitoring devices, and glucose monitoring devices. The glucose monitoring devices segment held the largest share in 2022. The glucose monitors devices segment held the largest share in 2022. The glucose monitoring devices segment is further bifurcated into self glucose monitors and continuous glucose monitors. Additionally, the pulse oximeters segment is subsegmented into handheld pulse oximeters, table-top pulse oximeters, and pulse oximeter accessories. The temperature monitoring devices segment into digital thermometers, infrared thermometers, mercury filled thermometers, and liquid crystal thermometers. Further, by blood pressure monitoring devices, the market is categorized into digital blood pressure monitors, analog blood pressure monitors, ambulatory blood pressure monitors, mercury blood pressure monitors, and blood pressure instrument accessories.
By end user, the Middle East & Africa vital signs monitoring devices market is segmented into hospitals & clinics, ambulatory care centers, home healthcare, and other. The hospitals & clinics segment held the largest share in 2022.
Koninklijke Philip NV, Medtronic Plc, Nihon Kohden, GE HealthCare Technologies Inc, OMRON corp, Masimo Corp, and Baxter Intonational Inc are some of the leading companies operating in the Middle East & Africa vital signs monitoring devices market.
Increasing Number of Product Launches and Approvals Fuels the Middle East & Africa Vital Signs Monitoring Devices Market
Companies in the Middle East & Africa vital signs monitoring devices market are designing, developing, and upgrading their existing products by harnessing ongoing advancements in medical technology. Frequent product launches significantly contribute to market growth by encouraging players to compete with each other by developing innovative products and obtaining regulatory approvals for their products. A few of the recent product launches and approvals that have significantly contributed to the market growth are mentioned below.- In April 2023, Honeywell introduced a real-time health monitoring system that captures patient's vital signs in hospitals and remote setups. The sensing technology incorporated in the system monitors vital signs through a skin patch and instantaneously notifies healthcare providers on their mobile devices and an online dashboard. Through this innovation, the company can aid improvements in patient care at home, hospitals, and ambulatory surgical centers.
- In June 2022, GE Healthcare announced the launch of Portrait Mobile, a product developed by combining wireless patient-worn sensors and a smartphone-style monitor. People wearing this monitoring device can move freely without any location restrictions. In August 2023, GE Healthcare received FDA approval for the Portrait Mobile and 510(k) approval for its Carescape Canvas patient monitoring platform.
- In April 2021, Oxehealth Service won FDA approval for its vital sign software, which can monitor heart rate and breathing with an overhead camera attached to the device. The product is suitable for end users in nursing homes and long-term care facilities.
- In January 2020, BioIntelliSense, Inc. announced the commercial launch of its Data-as-a-Service (DaaS) platform. It also announced receiving FDA 510(k) clearance for its BioSticker, an on-body sensor for remote care devices. Further, in July 2020, BioIntelliSense, Inc. collaborated with Royal Philips to integrate BioSticker into Philips's remote patient monitoring devices.
Middle East & Africa Vital Signs Monitoring Devices Market Overview
The vital signs monitoring devices market in Middle East & Africa is segmented into the UAE, Saudi Arabia, and South Africa. The UAE is the largest market for vital signs monitoring devices. The market is prominently driven by rise in respiratory diseases and diabetes.The growth of the country's medical devices and pharmaceutical sector is majorly attributed to the vast population and increasing prevalence of chronic diseases. The health systems in Saudi Arabia are witnessing increasing adoption of advanced medical devices to keep track of patient's health conditions. Greater awareness of health issues and an increase in the consumption of healthcare services sustain a substantial market for medical equipment. Also, the government and other organizations conduct conferences and symposiums and publish many research studies about monitoring devices. For instance, the Hospital and Research Center in Riyadh, Saudi Arabia, published a study about "perspectives from COPD subjects on portable long-term oxygen therapy devices" in June 2019. All these factors are likely to drive the market during the forecast period.
Also, Healthcare companies in the UAE strive to adopt cutting-edge healthcare technologies that provide their patients with unparalleled quality of service and the best treatment plans. In addition, the growing healthcare expenditure increases the demand for medical devices and pharmaceuticals. According to a "UAE Health Spending" study published in Healthcare Radius, the UAE spends ~3.5% of its GDP on healthcare, with approximately 70% coming from public spending and only 30% from the private sector. The UAE government has allocated US$ 1.33 billion (8.4% of the total budget) for healthcare and community protection in the federal budget for 2022-2026.
Middle East & Africa Vital Signs Monitoring Devices Market Segmentation
The Middle East & Africa vital signs monitoring devices market is segmented based on product, end user, and country.Based on product, the Middle East & Africa vital signs monitoring devices market is segmented into pulse oximeters, blood pressure monitors, temperature monitoring devices, and glucose monitoring devices. The glucose monitoring devices segment held the largest share in 2022. The glucose monitors devices segment held the largest share in 2022. The glucose monitoring devices segment is further bifurcated into self glucose monitors and continuous glucose monitors. Additionally, the pulse oximeters segment is subsegmented into handheld pulse oximeters, table-top pulse oximeters, and pulse oximeter accessories. The temperature monitoring devices segment into digital thermometers, infrared thermometers, mercury filled thermometers, and liquid crystal thermometers. Further, by blood pressure monitoring devices, the market is categorized into digital blood pressure monitors, analog blood pressure monitors, ambulatory blood pressure monitors, mercury blood pressure monitors, and blood pressure instrument accessories.
By end user, the Middle East & Africa vital signs monitoring devices market is segmented into hospitals & clinics, ambulatory care centers, home healthcare, and other. The hospitals & clinics segment held the largest share in 2022.
Koninklijke Philip NV, Medtronic Plc, Nihon Kohden, GE HealthCare Technologies Inc, OMRON corp, Masimo Corp, and Baxter Intonational Inc are some of the leading companies operating in the Middle East & Africa vital signs monitoring devices market.
Table of Contents
1. Introduction
3. Research Methodology
4. Middle East & Africa Vital Signs Monitoring Devices Market - Key Industry Dynamics
5. Vital Signs Monitoring Devices Market - Middle East & Africa Market Analysis
6. Middle East & Africa Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 - by Product
7. Middle East & Africa Vital Signs Monitoring Devices Market - Revenue and Forecast to 2030 - by End User
8. Middle East & Africa Vital Signs Monitoring Devices Market - Country Analysis
9. Vital Signs Monitoring Devices Market-Industry Landscape
10. Company Profiles
11. Appendix
List of Tables
List of Figures
Companies Mentioned
- Koninklijke Philip NV
- Medtronic Plc
- Nihon Kohden
- GE HealthCare Technologies Inc
- OMRON corp
- Masimo Corp
- Baxter Intonational Inc
